Drug Controller General
- All
- News
- Videos
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
All About PresVu, New Eye Drops That Can Remove Reading Glasses In 15 Mins
The Drugs Controller General of India has approved Entod Pharmaceuticals' PresVu eye drops, which is said to be a breakthrough in the treatment of presbyopia.
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Amazon, Flipkart, 20 Others Get Notice For Selling Drugs Without Licence
Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
-
Serum Institute To Launch India's First Cervical Cancer Vaccine
Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year after Drugs Controller General of India gives market authorisation.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
CBI's "Trap Operation" In Drug Regulator Office Over Bribery Case
The CBI on Monday apprehended some persons at the office of the Drugs Controller General of India in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
All About PresVu, New Eye Drops That Can Remove Reading Glasses In 15 Mins
The Drugs Controller General of India has approved Entod Pharmaceuticals' PresVu eye drops, which is said to be a breakthrough in the treatment of presbyopia.
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Amazon, Flipkart, 20 Others Get Notice For Selling Drugs Without Licence
Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
-
Serum Institute To Launch India's First Cervical Cancer Vaccine
Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year after Drugs Controller General of India gives market authorisation.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
CBI's "Trap Operation" In Drug Regulator Office Over Bribery Case
The CBI on Monday apprehended some persons at the office of the Drugs Controller General of India in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.
